Financial Data and Key Metrics Changes - SelectQuote reported a revenue growth of 12% year-over-year, totaling $537 million, driven by both Senior and healthcare services businesses [21][22] - Senior revenue grew 2% to $262 million, with adjusted EBITDA of $102 million, maintaining near record margins of 39% [22][23] - Healthcare services revenue increased by 26% year-over-year to $231 million, with membership growing 17% to 113,000 [24][25] - Operating cash flow for fiscal 2026 is expected to be between $25 million and $35 million, representing a significant increase compared to the previous year [30][32] Business Line Data and Key Metrics Changes - The Senior segment achieved an EBITDA margin of 39%, driven by strong marketing efficiency and agent productivity [21][22] - The healthcare services segment, particularly SelectRx, saw a 26% revenue increase, indicating strong demand and growth potential [24][25] - Life insurance revenue grew 9% to $44 million, with final expense premiums increasing by 24% [25][26] Market Data and Key Metrics Changes - The Medicare Advantage (MA) market experienced significant disruptions, with approximately 7% of plans canceled by carriers, compared to a historical average below 1% [13][14] - SelectQuote's recapture rate improved to 33%, reflecting effective customer retention strategies in a dynamic market [15][16] Company Strategy and Development Direction - SelectQuote aims to prioritize profitability and cash flow over growth, focusing on operational efficiency and strategic capital deployment [20][32] - The company has established a new $415 million credit facility, enhancing its capital flexibility and allowing for strategic investments [27][28] - SelectQuote's strategy includes leveraging its technology and data to improve service delivery and operational efficiency, particularly in the Senior segment [12][18] Management's Comments on Operating Environment and Future Outlook - Management acknowledged recent headwinds from a national carrier's marketing budget cuts, which are expected to impact fiscal 2026 by approximately $20 million [7][29] - Despite these challenges, management remains confident in the long-term growth, profitability, and cash flow potential of the business [8][29] - The company is focused on navigating the current market dynamics and believes it is well-positioned to capitalize on future opportunities [60][62] Other Important Information - SelectQuote's SelectRx service addresses inefficiencies in the medication system, contributing to improved health outcomes for seniors [18][19] - The company is committed to enhancing its negotiating position with pharmacy benefit managers (PBMs) due to its growing scale and successful engagement with complex member populations [68] Q&A Session Summary Question: Details on the PBM deal and its impact - Management highlighted the new multi-year PBM agreement provides stability and predictability, addressing the $20 million hit expected in fiscal 2026 [36][37] Question: Risks of other carriers following the marketing budget cuts - Management indicated that the decision was not unique to SelectQuote and expressed confidence in navigating through the challenges [38][39] Question: Opportunities for SelectQuote in the current market - Management emphasized the company's unique capabilities and operational efficiency, which position it well to capture market share despite current challenges [45][46] Question: SelectRx's negotiating position and scale - Management confirmed that the scale of SelectRx has enhanced its negotiating power with PBMs, allowing for deeper partnerships [68] Question: Incremental volume absorption at the Kansas facility - Management noted that the Kansas facility has significant capacity for expansion without requiring substantial new capital investments [70][71]
SelectQuote(SLQT) - 2026 Q2 - Earnings Call Transcript